NoNO-42
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for NoNO-42, covering 2024-05-16 to 2025-07-15. Get the full timeline:
Most recent: Clinical Trial Update: NoNO-42 Trial in Acute Ischemic Stroke Patients Selected for Thrombolysis With or Without Endovascular Thrombectomy [Phase 2]